ERBB2 and breast carcinoma: Breast cancer (BC) is a heterogeneous disease classified into four subtypes: Luminal A, Luminal B, human epidermal growth factor receptor 2 (HER2)-enriched, and triple-negative, based on biomarker expression [1,2].